GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon
- PMID: 19276343
- PMCID: PMC3747834
- DOI: 10.1158/0008-5472.CAN-08-4466
GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon
Abstract
Short-chain fatty acids, generated in colon by bacterial fermentation of dietary fiber, protect against colorectal cancer and inflammatory bowel disease. Among these bacterial metabolites, butyrate is biologically most relevant. GPR109A is a G-protein-coupled receptor for nicotinate but recognizes butyrate with low affinity. Millimolar concentrations of butyrate are needed to activate the receptor. Although concentrations of butyrate in colonic lumen are sufficient to activate the receptor maximally, there have been no reports on the expression/function of GPR109A in this tissue. Here we show that GPR109A is expressed in the lumen-facing apical membrane of colonic and intestinal epithelial cells and that the receptor recognizes butyrate as a ligand. The expression of GPR109A is silenced in colon cancer in humans, in a mouse model of intestinal/colon cancer, and in colon cancer cell lines. The tumor-associated silencing of GPR109A involves DNA methylation directly or indirectly. Reexpression of GPR109A in colon cancer cells induces apoptosis, but only in the presence of its ligands butyrate and nicotinate. Butyrate is an inhibitor of histone deacetylases, but apoptosis induced by activation of GPR109A with its ligands in colon cancer cells does not involve inhibition of histone deacetylation. The primary changes in this apoptotic process include down-regulation of Bcl-2, Bcl-xL, and cyclin D1 and up-regulation of death receptor pathway. In addition, GPR109A/butyrate suppresses nuclear factor-kappaB activation in normal and cancer colon cell lines as well as in normal mouse colon. These studies show that GPR109A mediates the tumor-suppressive effects of the bacterial fermentation product butyrate in colon.
Figures





Similar articles
-
Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis.Immunity. 2014 Jan 16;40(1):128-39. doi: 10.1016/j.immuni.2013.12.007. Epub 2014 Jan 9. Immunity. 2014. PMID: 24412617 Free PMC article.
-
IFNγ Induces DNA Methylation-Silenced GPR109A Expression via pSTAT1/p300 and H3K18 Acetylation in Colon Cancer.Cancer Immunol Res. 2015 Jul;3(7):795-805. doi: 10.1158/2326-6066.CIR-14-0164. Epub 2015 Mar 3. Cancer Immunol Res. 2015. PMID: 25735954 Free PMC article.
-
Colonic gene expression in conventional and germ-free mice with a focus on the butyrate receptor GPR109A and the butyrate transporter SLC5A8.J Gastrointest Surg. 2010 Mar;14(3):449-61. doi: 10.1007/s11605-009-1045-x. Epub 2009 Dec 22. J Gastrointest Surg. 2010. PMID: 20033346
-
Review article: the role of butyrate on colonic function.Aliment Pharmacol Ther. 2008 Jan 15;27(2):104-19. doi: 10.1111/j.1365-2036.2007.03562.x. Epub 2007 Oct 25. Aliment Pharmacol Ther. 2008. PMID: 17973645 Review.
-
Microbiota-derived butyrate regulates intestinal inflammation: Focus on inflammatory bowel disease.Pharmacol Res. 2020 Sep;159:104947. doi: 10.1016/j.phrs.2020.104947. Epub 2020 May 31. Pharmacol Res. 2020. PMID: 32492488 Review.
Cited by
-
Control of lymphocyte functions by gut microbiota-derived short-chain fatty acids.Cell Mol Immunol. 2021 May;18(5):1161-1171. doi: 10.1038/s41423-020-00625-0. Epub 2021 Apr 13. Cell Mol Immunol. 2021. PMID: 33850311 Free PMC article. Review.
-
Microbial Metabolites in Colorectal Cancer: Basic and Clinical Implications.Metabolites. 2021 Mar 10;11(3):159. doi: 10.3390/metabo11030159. Metabolites. 2021. PMID: 33802045 Free PMC article. Review.
-
The clinical evidence for postbiotics as microbial therapeutics.Gut Microbes. 2022 Jan-Dec;14(1):2117508. doi: 10.1080/19490976.2022.2117508. Gut Microbes. 2022. PMID: 36184735 Free PMC article. Review.
-
The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics.Nat Rev Gastroenterol Hepatol. 2021 Sep;18(9):649-667. doi: 10.1038/s41575-021-00440-6. Epub 2021 May 4. Nat Rev Gastroenterol Hepatol. 2021. PMID: 33948025 Free PMC article. Review.
-
Gut microbiota-derived metabolites in the regulation of host immune responses and immune-related inflammatory diseases.Cell Mol Immunol. 2021 Apr;18(4):866-877. doi: 10.1038/s41423-021-00661-4. Epub 2021 Mar 11. Cell Mol Immunol. 2021. PMID: 33707689 Free PMC article. Review.
References
-
- Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science. 2001;292:1115–8. - PubMed
-
- Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science. 2005;307:1915–20. - PubMed
-
- Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027–31. - PubMed
-
- Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: Roles of resistant starch and nonstarch polysaccharides. Physiol Rev. 2001;81:1031–64. - PubMed
-
- Mortensen PB, Clausen MR. Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease. Scand J Gastroenterol. 1996;216:132–48. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials